Document is current

Any future updates will be listed below

Authors’ reply to “Outcomes for metastatic triple-negative breast cancer patients treated with sacituzumab govitecan in clinical studies and real-world studies: a single-arm meta-analysis”

Crossref DOI link: https://doi.org/10.1007/s00228-026-04038-2

Published Online: 2026-04-01

Published Print: 2026-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark